News

• Shareholder Letter from Chief Executive Officer Brent Ness

  March 19, 2026

• Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

  March 19, 2026

• Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts

  March 19, 2026

• Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet

  March 17, 2026

• Aclarion CEO Brent Ness to Attend LSI USA 2026

  March 12, 2026

• Aclarion Publishes 2026 Shareholder Letter from the Chairman

  February 5, 2026

• 2026 Annual Shareholder Letter from the Chairman

  February 5, 2026

• Aclarion Adds High-Volume Practice, Source Healthcare, to Support Nociscan Growth and Real-World Evidence Generation

  February 3, 2026

• Aclarion Strengthens Balance Sheet and Extends Cash Runway Into 2028

  January 13, 2026

• Aclarion Provides 2025 Update and 2026 Corporate Outlook

  January 8, 2026